Zuclopenthixol Acetate (Clopixol Acuphase) Monitoring Guideline

Name/Title	Zuclopenthixol Acetate (Clopixol Acuphase) Monitoring Guideline (PDF)
Document ID	TS4KSNFPVEZQ-210-16850
Current from	09/08/2018
Coverage	WACHS
Policy Type	Guideline
Summary	This guideline sets out how Zuclopenthixol acetate (Clopixol Acuphase) - an intermediate acting intramuscular injection, indicated in managing acute psychosis or mania in adults, is administered in a Mental Health Inpatient Unit (only).

FEEDBACK